BRTX

BioRestorative Therapies Inc

1.58

Oct 26 • 3:59 PM ET -0.04 (-2.47%)

1.52

Aftermarket • 7:50 PM ET -0.06 (-3.80%)

Healthcare Biotechnology USA Nano NASD

Peers: BBLG FBLG CELZ LGVN BCDA PLUR CAPR MESO BSEM LCTX

| Held by: VXF

Scroll to Statements

Index	-
Market Cap	2.18M
Enterprise Value	-1.38M
Income	-11.06M
Sales	0.36M
Book/sh	2.38
Cash/sh	2.60
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	14
IPO	Jun 28, 1999

P/E	-
Forward P/E	-
PEG	-
P/S	6.06
P/B	0.67
P/C	0.61
P/FCF	-
EV/EBITDA	-
EV/Sales	-3.83
Quick Ratio	2.35
Current Ratio	2.35
Debt/Eq	0.01
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-22.40
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	24.33% 43.92%
Sales past 3/5Y	44.27% 36.11%
EPS Y/Y TTM	25.62%
Sales Y/Y TTM	-8.47%
EPS Q/Q	80.98%
Sales Q/Q	-7.32%
Earnings	May 20
EPS/Sales Surpr.	10.81% -86.67%

Insider Own	6.22%
Insider Trans	0.00%
Inst Own	13.84%
Inst Trans	9.57%
ROA	-147.75%
ROE	-241.14%
ROIC	-365.43%
Gross Margin	33.24%
Oper. Margin	-3975.00%
Profit Margin	-3089.55%
SMA20	-14.25%
SMA50	-42.32%
SMA200	-76.53%
Trades

Shs Outstand	1.38M
Shs Float	1.30M
Short Float	1.01%
Short Ratio	0.48
Short Interest	0.01M
52W High	34.00 -95.35%
52W Low	1.28 23.44%
Volatility	9.32% 10.67%
ATR (14)	0.21
RSI (14)	29.17
Beta	0.90
Rel Volume	1.28
Avg Volume	27.44K
Volume	35,011

Perf Week	-1.25%
Perf Month	-38.04%
Perf Quarter	-70.37%
Perf Half Y	-66.05%
Perf YTD	-93.28%
Perf Year	-94.97%
Perf 3Y	-95.75%
Perf 5Y	-99.40%
Perf 10Y	-100.00%
Recom	1.00
Target Price	20.00
Prev Close	1.62
Price	1.58
Change %	-2.47%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-06-26	Downgrade	Maxim Group	Buy → Hold

Sep-02-26 05:27PM	BioRestorative Therapies Announces Reverse Stock Split (GlobeNewswire) -28.76%
Jun-25-26 08:15AM	BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform (GlobeNewswire)
Jun-18-26 08:15AM	BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth (GlobeNewswire)
May-27-26 07:45AM	Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) (PR Newswire) +73.30%
May-26-26 11:00AM	BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data (GlobeNewswire) +20.10%
11:00AM	Loading…
May-13-26 11:00AM	BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals (GlobeNewswire) -5.82%
May-07-26 12:00PM	BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease (GlobeNewswire) -8.09%
Apr-30-26 10:36AM	BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform (GlobeNewswire) +11.60%
Apr-21-26 08:00AM	BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform (GlobeNewswire) -7.82%
Apr-07-26 08:15AM	BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform (GlobeNewswire)
Mar-30-26 08:00AM	BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease (GlobeNewswire) -10.94%
Mar-19-26 08:00AM	BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease (GlobeNewswire) +11.93%
Mar-05-26 08:00AM	BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 (GlobeNewswire)
Mar-04-26 08:00AM	BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy (GlobeNewswire)
Feb-24-26 08:30AM	BioRestorative Expands Global Protection for ThermoStem, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs (GlobeNewswire) +37.01%
08:30PM	Loading…
Feb-13-26 08:30PM	BioRestorative Announces Closing of $5.0 Million Public Offering (GlobeNewswire) +16.09% -6.32%
Feb-11-26 10:30PM	BioRestorative Announces Pricing of $5.0 Million Public Offering (GlobeNewswire) -35.41% -40.50%
07:30AM	BioRestorative Announces Positive Outcome from Type B Meeting with FDA (GlobeNewswire)
Feb-10-26 08:00AM	BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease (GlobeNewswire) -38.87%
Nov-17-25 07:00AM	BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease (GlobeNewswire) -6.77%
Nov-13-25 12:01AM	BioRestorative Therapies Inc (BRTX) Q3 2025 Earnings Call Highlights: Strategic Advancements ... (GuruFocus.com) -9.42%
Nov-12-25 06:25PM	Biorestorative Therapies, Inc. (BRTX) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
Nov-10-25 09:10AM	CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-05-25 04:30PM	BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025 (GlobeNewswire)
Oct-27-25 07:30AM	BioRestorative Awarded Notice of Allowance for Japanese Patent - Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market (GlobeNewswire)
Oct-22-25 09:35AM	BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio (GlobeNewswire)
Oct-15-25 09:35AM	BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit (GlobeNewswire)
Oct-13-25 09:40AM	Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year? (Zacks)
Oct-07-25 09:25AM	BioRestorative CEO Lance Alstodt Interviewed on "The Big Biz Show" (GlobeNewswire) +5.88%
02:28PM	Loading…
Oct-06-25 02:28PM	BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market (GlobeNewswire)
Sep-26-25 09:40AM	Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year? (Zacks)
Aug-18-25 09:40AM	Are Medical Stocks Lagging Black Diamond Therapeutics (BDTX) This Year? (Zacks)
Aug-13-25 03:13AM	BioRestorative Therapies Inc (BRTX) Q2 2025 Earnings Call Highlights: Revenue Surge Amid ... (GuruFocus.com)
Aug-12-25 06:05PM	Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
04:05PM	BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
Aug-07-25 06:35PM	Zymeworks Inc. (ZYME) Tops Q2 Earnings and Revenue Estimates (Zacks)
Aug-06-25 08:15AM	Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-05-25 04:30PM	BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025 (GlobeNewswire)
Jun-18-25 09:35AM	BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates (GlobeNewswire)
Jun-17-25 09:25AM	BioRestorative Announces Share Repurchase Program (GlobeNewswire) +6.17%
Jun-13-25 07:45AM	BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 - an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease (GlobeNewswire) -16.00%
Jun-10-25 08:00AM	BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team (GlobeNewswire)
Jun-09-25 07:45AM	BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025 (GlobeNewswire)
May-15-25 08:55AM	Q1 2025 BioRestorative Therapies Inc Earnings Call (Thomson Reuters StreetEvents)
03:17AM	BioRestorative Therapies Inc (BRTX) Q1 2025 Earnings Call Highlights: Navigating Challenges ... (GuruFocus.com)
May-14-25 06:35PM	Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:05PM	BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
May-13-25 09:50AM	Stoke Therapeutics, Inc. (STOK) Tops Q1 Earnings and Revenue Estimates (Zacks) -7.09%
09:15AM	Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data (GlobeNewswire)
May-12-25 05:30PM	Coherus BioSciences (CHRS) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-08-25 04:30PM	BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025 (GlobeNewswire)
May-07-25 09:15AM	BioRestorative to Present a BRTX-100 Clinical Update at ISCT 2025 (GlobeNewswire)
Apr-15-25 08:30AM	BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities (GlobeNewswire)
Apr-10-25 09:15AM	BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States (GlobeNewswire) -5.71%
Mar-27-25 08:10PM	BioRestorative Therapies, Inc. (BRTX) Q4 2024 Earnings Call Transcript (Seeking Alpha)
04:05PM	BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update (GlobeNewswire)
Mar-20-25 04:30PM	BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025 (GlobeNewswire)
Feb-27-25 09:45AM	BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain (GlobeNewswire) -15.18%
Feb-26-25 08:15PM	BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update (GlobeNewswire)
Feb-25-25 08:00AM	BioRestorative to Provide a Positive FDA Update on Clinical Pipeline (GlobeNewswire) +13.75%
Feb-20-25 08:30AM	BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program (GlobeNewswire)
Feb-10-25 07:00AM	BRTX-100 Front and Center at ORS 2025 (GlobeNewswire) +6.09%
Dec-05-24 06:45AM	BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem Metabolic Disease Program (GlobeNewswire)
Nov-13-24 07:00AM	BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data (GlobeNewswire) -6.10%
Nov-12-24 04:05PM	BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Nov-06-24 07:00AM	BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium (GlobeNewswire) +6.45%
Nov-05-24 07:10AM	BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health (GlobeNewswire)
Oct-31-24 07:00AM	BioRestorative Therapies Receives Patent Allowance for ThermoStem Metabolic Disease Program (GlobeNewswire)
Oct-10-24 07:00AM	BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events (GlobeNewswire)
Oct-03-24 04:15PM	BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference (GlobeNewswire)
Sep-19-24 06:55AM	BioRestorative Therapies' IFATS 2024 Presentation to Feature ThermoStem Platform's Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs (GlobeNewswire)
Aug-13-24 05:55PM	Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Aug-06-24 04:05PM	BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024 (GlobeNewswire)
Jul-23-24 07:10AM	BioRestorative Therapies' Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine (GlobeNewswire)
Jun-27-24 07:40AM	BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem Metabolic Disease Program (GlobeNewswire) -9.41%
Jun-17-24 07:05AM	BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results (GlobeNewswire) +20.00%
Jun-13-24 07:00AM	BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem Metabolic Disease Program (GlobeNewswire) +44.44%
Jun-12-24 08:52AM	BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +15.38%
Jun-11-24 05:50PM	Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Jun-04-24 08:50AM	BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference (GlobeNewswire) -5.43%
May-24-24 07:45PM	BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice (GlobeNewswire)
May-15-24 09:00AM	BioRestorative Therapies (NASDAQ:BRTX) Announces Commercial Agreement With Cartessa, Further Expanding Into $75.46 Billion Aesthetics Market (ACCESSWIRE)
May-14-24 04:10PM	BioRestorative Therapies Provides First Quarter 2024 Business Update (GlobeNewswire)
May-08-24 07:30AM	BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity (GlobeNewswire)
Apr-30-24 04:15PM	BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 (GlobeNewswire) +14.52%
07:30AM	BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology (GlobeNewswire)
Apr-16-24 07:45AM	BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment (GlobeNewswire)
Apr-14-24 03:00PM	10 Micro-Cap Healthcare Stocks Insiders Are Buying (Insider Monkey)
Apr-08-24 07:45AM	BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease (GlobeNewswire)
Apr-03-24 04:38PM	BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants (GlobeNewswire)
Apr-02-24 09:53AM	BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
Apr-01-24 07:45AM	BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K (GlobeNewswire)
Mar-11-24 04:15PM	BioRestorative Therapies to Participate in the 36th Annual ROTH Conference (GlobeNewswire)
Feb-14-24 09:15AM	BioRestorative Therapies Presents Promising Data at Orthopaedic Research Society (ORS) 2024 Annual Meeting (ACCESSWIRE)
Feb-06-24 08:05AM	BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market (GlobeNewswire) -54.49%
Feb-05-24 07:30AM	BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease (GlobeNewswire) +23.21%
Feb-01-24 07:30AM	BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting (GlobeNewswire) +32.52%
Dec-12-23 09:15AM	BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity Program (GlobeNewswire) +5.75%

Show Previous News

BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.

Interim CEO & DirectorMr. Mika Grasso

CFO & TreasurerMs. Anna Skowron

Head of Global Commercial OperationsMs. Crystal Romano

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BRTX

BioRestorative Therapies Inc

Upgrade your Finviz experience